Journal of Molecular Biology

Xiaobin Li is the Deputy Director of the Drug Screening Laboratory at the Biology Institute of Shandong Academy of Sciences. She obtained her MSc from Jinan University in 2011 and her PhD with summa cum laude from Shandong University in 2015. She has led and participated in multiple national and provincial research projects and has published over 70 SCI-indexed articles and holds more than 40 national invention patents.

• Natural products from marine fungi
• Marine phospholipids
• Drug screening using zebrafish models
• Lipidomics and bioactive compound evaluation

1. Principal investigator/co-investigator of 11 national and provincial research projects

2. Part-time Lecturer, Jining Medical College

3. Cooperative Master’s Supervisor, Shandong University

4. Member of multiple national and provincial scientific and professional committees

1. Comparative bioactivity profile of phospholipids from three marine byproducts based on the zebrafish model — J Food Biochem, 2022.

2. Recent Advances of the Zebrafish Model in the Discovery of Marine Bioactive Natural Products — Marine Drugs, 2024. 

3. Metabolomics-based profiling of anti-inflammatory compounds from Mentha spicata in Shanghe, China — Heliyon, 2024.

4. Separation, identification and cardiovascular activities of phospholipid classes from the head of Penaeus vannamei by lipidomics and zebrafish models — Food & Function, 2021. 

5. Chenopodium album L. herb attenuates inflammation by modulating multiple signaling pathways in zebrafish: Network pharmacology analysis, transcriptomics analysis and experimental verification — Journal of Functional Foods, 2025. 

6. Diterpenoids from Marmoritis complanata and their anti-inflammatory activity in zebrafish — Phytochemistry, 2025.